Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous insulin infusion for anti-inflammatory effects in non-diabetic cardiac surgery
2007-001481-32Phase 3Completed
- Sponsor
- Policlinico di Bari
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of human insulin in cardiac disease and Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by Policlinico di Bari. Primary endpoints: C-reactive protein (CRP) levels, Interleukin-1 (IL-1) levels and 2 more. Started Mar 2007; status: completed.
02
Drugs
human insulin
03
Conditions
cardiac diseaseSystemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on 2007-001481-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001481-32.